Tildrakizumab in the treatment of psoriasis: latest evidence and place in therapy

• প্রধান লেখক: Deeti J. Pithadia (লেখক), Kelly A. Reynolds (লেখক), Erica B. Lee (লেখক), Wilson Liao (লেখক), Jashin J. Wu (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: SAGE Publishing, 2019-08-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Psoriasis is a chronic inflammatory disorder that is clinically characterized by scaly cutaneous plaques. New evidence suggests that dysregulation of interleukin (IL)-23, a key cytokine in the T-helper-17 pathway, plays a vital role in the development of psoriatic systemic inflammation. The novel bi...